Finance News – Sanofi
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Crypto Assets
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Sec
Bse
Eth
Ipo
Index
Solana
Trade
Earnings
Inflation
Revenue
Coinbase
Interest Rates
Token
China
Sensex
Wall Street
Nasdaq
Traders
Gold
Federal Reserve
Treasury
Nse
Bse Sensex
Usd
Economy
Profit
Tesla
Trade War
Nifty
Defi
Air India
Procap
Trezor
Stolen Funds
British State
King River Resources
Premier Foods
International Tourists
Revenue Potential
Armed Forces
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →
Investopedia • Jun 02, 2025
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.
Read Full Article →
Investopedia • May 22, 2025
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
The company's market value increased significantly after the announcement of its upcoming purchase by a major pharmaceutical firm, highlighting investor confidence in the potential...
Read Full Article →